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Peripheral blood myelomonocytic cells are important
for cytomegalovirus dissemination to distal organs
such as salivary glands where persistent replication
and shedding dictates transmission patterns. We
find that this process is markedly enhanced by
the murine cytomegalovirus (MCMV)-encoded CC
chemokine, MCK2, which promotes recruitment of
CX3CR1hi patrolling monocytes to initial infection
sites in the mouse. There, these cells become in-
fected and traffic via the bloodstream to distal
sites. In contrast, inflammatory monocytes, the other
major myelomonocytic subset, remain virus negative.
CX3CR1 deficiency prevents patrolling monocyte
migration on the vascular endothelium and interrupts
MCMV dissemination to the salivary glands indepen-
dent of antiviral NK and T cell immune control. In this
manner, CX3CR1hi patrolling monocytes serve as im-
mune-privileged vehicles to transport MCMV via the
bloodstream to distal organs. MCMV commandeers
patrolling monocytes to mediate systemic infection
andseedapersistent reservoir essential for horizontal
transmission.
INTRODUCTION
Human cytomegalovirus (HCMV) is an opportunistic betaher-
pesvirus of medical significance in settings of compromised
immune systems (Mocarski et al., 2013). HCMV has a tropism
for epithelial, endothelial, myeloid, neuronal, and fibroblast
cell types in patients and tissue culture settings (Revello and
Gerna, 2010); however, pathogenesis in immunocompetent in-
dividuals remains to be established. Different peripheral blood
leukocyte (PBL) subsets have been implicated in viremia (Rev-
ello et al., 1998) and latency (Reeves and Sinclair, 2008; Slo-
bedman and Mocarski, 1999) in both immune-compromised
and -competent subjects. Nonpermissive monocytes likely
serve as latent reservoirs that support dissemination by
maturing into permissive macrophages or dendritic cells that
reactivate virus (Hertel et al., 2003; Reeves et al., 2005; Sinclair,
2008b). Overall, a definitive understanding of the cell type thatCell Hodisseminates virus or contributes to the latent reservoir remains
to be elucidated.
Murine CMV (MCMV) has revealed key principles of the virus-
host interaction involved in immune control, pathogenesis, and
latency (Daley-Bauer and Mocarski, 2012; Reddehase et al.,
2008; Scalzo et al., 2007). Virus exposure results in systemic
infection. Dissemination from initial infection sites occurs via
a leukocyte-associated viremia, seeding distal organs such as
salivary glands—a site of persistent infection that is key to trans-
mission (Collins et al., 1994; Stoddart et al., 1994). Host innate
and adaptive immune mechanisms collaborate to control infec-
tion, setting the stage for lifelong latency (Pollock et al., 1997;
Reddehase et al., 2008). Studies showing MCMV seeding
visceral organs directly following systemic inoculation (Hsu
et al., 2009; Sacher et al., 2008) add to earlier observations
that systemic infection relies on bone marrow (BM)-derived
myelomonocytic cells that disseminate virus via the blood
(Bale and O’Neil, 1989; Cheung and Lang, 1977; Noda et al.,
2006; Stoddart et al., 1994). Further, macrophages are a major
latent reservoir (Pollock et al., 1997), analogous to humans
(Revello et al., 1998) but difficult to track in naturally infected
immunocompetent adults. Regardless of immune status, cell-
free virus is not produced inmice (Roback et al., 2006) or humans
(Gilbert et al., 1989; Yeager et al., 1981). A blood mononuclear
phagocyte transports MCMV (Stoddart et al., 1994), potentially
acquiring virus from vascular endothelial cells at initial sites
(Sacher et al., 2008). A model consistent with current concepts
suggests local infection spreads once vascular endothelial cells
pass the virus to monocytes as they traverse the vasculature
(Mocarski et al., 2006) to promote acute systemic infection.
Once resolved, latency may be preserved in BM-derived,
tissue-resident macrophages or endothelial cells (Pollock et al.,
1997; Reddehase et al., 2008). Monocytes circulate in the
blood and give rise to macrophages (Auffray et al., 2007; Yona
et al., 2013), underscoring a need to clarify their role during
CMV pathogenesis.
Two functionally distinct monocyte subsets give rise tomacro-
phages and dendritic cells in humans and mice (Auffray et al.,
2009). Inflammatory monocytes (IMs) and patrolling monocytes
(PMs) are distinguished based on migratory and proinflamma-
tory differences (Robbins and Swirski, 2010). Both subsets
have been implicated in CMV pathogenesis (Daley-Bauer and
Mocarski, 2012; Daley-Bauer et al., 2012). In mice, BM-resident
IMs become dramatically mobilized to accumulate at infection
sites (Serbina et al., 2008), whereas PMs circulate continuouslyst & Microbe 15, 351–362, March 12, 2014 ª2014 Elsevier Inc. 351
Figure 1. CX3CR1 Deficiency Disrupts MCMV Dissemination to the
Salivary Glands
(A) Viral titers in Cx3cr1gfp/+ (black) and Cx3cr1gfp/gfp (gray) mice at 14 days
following systemic (ip) or FP inoculation.
(B) Viral titers in salivary glands of Cx3cr1gfp/+ and Cx3cr1gfp/gfp mice at 1, 3, 5,
7, and 14 days following FP inoculation. Data points represent the mean viral
titers ±SE for groups of five mice. Horizontal dashed lines indicate the limit of
detection of the assay. Panels represent at least two independent experi-
ments. *p < 0.05; **p < 0.01; ***p < 0.001; ns indicates not significant (p > 0.05).
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contribute to early inflammatory responses (Auffray et al.,
2007). Human CD14+ IMs and CD16+ PMs (Cros et al., 2010)
parallel murine CX3CR1intLy6Chi IMs and CX3CR1hiLy6C PMs
(Geissmann et al., 2003). Murine PMs arise from both IM-depen-
dent (Sunderko¨tter et al., 2004; Varol et al., 2007; Yona et al.,
2013) and IM-independent precursors (Hanna et al., 2011).
Nucleic-acid-mediated inflammatory cues trigger PMs to adhere
to the vasculature without extravasating into inflamed tissues
(Carlin et al., 2013)—a pattern of contact and migration likely to
facilitate MCMV dissemination. The established value of het-
erozygous Cx3cr1gfp/+ and homozygous Cx3cr1gfp/gfp mice to
identify PMs (Geissmann et al., 2003) and dissect their function
(Auffray et al., 2009) presents an opportunity to determine the
contribution of CX3CR1hi PMs in MCMV pathogenesis.
CMV-encoded chemokines support dissemination by
enhancing the inflammatory response (Daley-Bauer and Mocar-
ski, 2012). HCMV UL146-encoded vCXCL1 (Penfold et al., 1999)
and MCMV m131-m129-encoded MCK2 (MacDonald et al.,
1999) recruit myeloid leukocytes. MCK2 expression promotes
leukocyte recruitment, increasing viremia and promoting
dissemination to ensure optimal systemic infection (Fleming
et al., 1999; Saederup et al., 1999, 2001). MCK2-enhanced
viremia and dissemination proceed independent of adaptive
immunity in immunocompromised an immunocompetent mice
(Mocarski et al., 2006; Noda et al., 2006). Although IMs do not
disseminate virus, they respond to MCK2 to modulate antiviral
CD8 T cell responses (Daley-Bauer et al., 2012). Plasmacytoid
dendritic cells also respond toMCK2 andmodulate T cell control
of virus (Wikstrom et al., 2013). Most recent evidence suggests
MCK2 mediates infection of macrophages (Wagner et al.,
2013). Thus, MCK2 may potentially control leukocyte migration,
influence viral clearance, and dictate susceptibility to infection.
We investigated the contribution of PMs to MCMV infection
and show that the virus depends on MCK2 to regulate PM
recruitment to inoculation sites. These monocytes become in-
fected and traffic via the blood to disseminate virus to salivary352 Cell Host & Microbe 15, 351–362, March 12, 2014 ª2014 Elsevieglands and other tissues. CMV therefore employs the virus-
encoded chemokine to hijack an early-responding immune
component as a key step in pathogenesis of infection.
RESULTS
CX3CR1 Is Necessary for Viral Dissemination following
Local Inoculation
OptimalMCMVdissemination via the blood to the salivary glands
relies on MCK2-dependent recruitment of a monocytic PBL
independent of CCR2-mediated IM mobilization (Daley-Bauer
et al., 2012; Noda et al., 2006; Stoddart et al., 1994). We sought
to define CX3CR1-dependent PM control of viral dissemination
during MCMV infection. Although CX3CR1 deficiency did not
interrupt dissemination to the salivary glands following sys-
temic intraperitoneal (ip) inoculation, dissemination from a local
footpad (FP) inoculation site was compromised (Figure 1A).
Thus, direct delivery of cell-free virus to many organs (Hsu
et al., 2009) overcomes a crucial CX3CR1-dependent step that
is needed when inoculation mimics natural biting and grooming
transmission patterns. Cx3cr1gfp/gfp mice showed R1,000-fold
lower viral titers compared to Cx3cr1gfp/+ controls. At 7 days
postinfection (dpi), virus replicates in associated brown fat,
whereas virus replication is localized to salivary gland acinar
epithelial cells at 14 dpi (Stoddart et al., 1994). Regardless of
inoculation route, seeding of acinar epithelial cells depends on
a host monocytic leukocyte (Noda et al., 2006; Saederup et al.,
1999, 2001). Viral titers increased dramatically from 7–14 dpi in
Cx3cr1 gfp/+, but not Cx3cr1gfp/gfp, mice (Figure 1B), revealing
the crucial contribution of the CX3CL1-CX3CR1 axis in MCMV
dissemination.
Identification of CX3CR1hi PMs
We took advantage of GFP expression combined with discrimi-
natory cell surface markers to distinguish PMs from other
CX3CR1-expressing PBL populations by flow cytometry. Singlet
CD45+ PBLs were gated to exclude CX3CR1+ NK1.1+ natural
killer (NK) and CD3+ T cells (Stievano et al., 2004). GFPhi PMs
were identified as CD115+Ly6CGr1CD11b+F4/80+ cells
that expressed CD11c but lacked the adhesion molecules
CD31 and CD62L. In contrast, GFPint IMs were identified
as CD115+Ly6C+Gr1loCD11b+F4/80lo cells with the adhesion
molecules but without CD11c (Figure 2). These markers provide
a definitive identification of PMs (Auffray et al., 2009).
Viral Chemokine PromotesBiphasic Recruitment of PMs
to Local Sites of Infection
The MCK2-enhanced myelomonocytic cell recruitment respon-
sible for MCMV dissemination peaks in numbers at 3 dpi (Noda
et al., 2006). PMs respond very early, within a few hours of
bacterial inoculation (Auffray et al., 2007). Given that the cell
that disseminates MCMV must be recruited early, we evaluated
the impact of MCK2 on PMs. PM recruitment to inoculated
FPs was influenced by host CX3CR1 and viral MCK2 function.
Except for CD115 downmodulation, infection did not alter the
CD115+Ly6CGr1CD11b+F4/80+CD11c+ phenotype of PMs.
PMs were initially recruited between 8 and 20 hr postinfection
(hpi) in Cx3cr1gfp/+ or Cx3cr1gfp/gfp FPs exposed to Mck2+ virus
(Figure 3A). A similar pattern of early recruitment was observed inr Inc.
Figure 2. Characterization of CX3CR1hi
PMs in Peripheral Blood
(A–D) Gating strategy for PM (patrolling mono-
cyte), IM (inflammatory monocyte), and Neut
(neutrophil) subpopulations. CD45+CD11b+ PBLs,
gated to exclude T cells (TCRb) and NK cells
(NK1.1), were subjected to evaluation for Ly6C
and CX3CR1 levels characteristic of these sub-
populations.
(E–M) Detection of monocyte subset-defining
phenotypic markers on PMs (black, solid line), IMs
(gray, dashed lines), and negative controls (filled
histogram). PBLs were obtained from naive
Cx3cr1gfp/+ mice and phenotyped by flow cy-
tometry following doublet exclusion. Plots are of
data from one mouse representative of a group of
four mice.
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contrast, when host CX3CR1 and viral MCK2 signaling were dis-
rupted together, recruitment failed. Thus, these two chemokine
pathways independently promoted early PM recruitment.
MCK2 was sufficient to drive robust recruitment independent
of CX3CR1 (Figure 3A), suggesting that viral chemokine elabora-
tion ensures early PM recruitment even when the CX3CL1-
CX3CR1 axis is not engaged.
The initial appearance of PMs may influence recruitment of
other immune cells to sites of infection. NK cell frequencies
increased after 12 hpi in all settings, paralleling the rise in PMs,
with a similar dependence on host CX3CR1 and viral MCK2
signaling (Figures 3C and 3D). In contrast, IM recruitment prior
to 24 hpi proceeded independent of host or viral chemokine
signaling (Figures 3E and 3F), a pattern shared by neutrophils
and T cells (data not shown). Although additional mechanisms
may be involved, the data suggest that the early MCK2-driven
PM migration initiates an NK cell response that is sustained by
IMs later during infection (Crane et al., 2009; Hokeness et al.,
2005). Though potentially important in orchestration of the innate
response, this complex relationship will require further study.Cell Host & Microbe 15, 351–36Maximal inflammation coincides with
peak viral titers in FPs at 3–5 dpi (Sae-
derup et al., 2001). When the contribution
of CX3CR1hi monocytes to the inflamma-
tory infiltrate was followed up to 5 dpi, a
second wave of PM recruitment into FPs
was observed at 3 dpi. Unlike the early
recruitment pattern (Figure 3A), the 3 dpi
pattern required a combination of host
and viral chemokine signaling (Figure 3G).
In all but one setting, PM numbers
mirrored swelling such that host and
viral chemokine signaling together were
necessary to produce full inflammation
(Figures 3G and 3H). Thus, MCK2 seems
to influence levels of PM recruited to the
inoculated site, ensuringoptimal numbers
of susceptible cells are present when viral
progeny are produced. Consistent with
PM recruitment data, combined MCK2and CX3CR1 function contribute to optimal virus dissemination
to salivary glands. These titers were 1,000-fold higher at 14 dpi
than when either chemokine system was compromised (Fig-
ure S1 available online). In contrast to a mutant virus used to
implicate a role for MCK2 in mediating macrophage infection
(Wagner et al., 2013), our MCK2-deficient virus efficiently in-
fected primary BM-derived macrophages (BMDMs) as well as
J774macrophage cells (Figure S2). Thus, the K181MCMV strain
used here does not rely on MCK2 to facilitate entry into macro-
phages, in contrast to the behavior of the bacmid derivative of
MCMV strain Smith. While further comparisons are beyond the
scope of this work, extensive genome sequence differences
between viral strains likely underlie the biological differences
that have been observed.
PMs Are the Vehicles of MCMV Dissemination
Given the evidence that viral MCK2 and host CX3CR1 collabo-
rate to recruit PMs to inoculation sites, we next investigated
PM contribution to cell-associated viremia that peaks by 3–5
dpi (Noda et al., 2006; Saederup et al., 1999, 2001). Viremia
was not detected following FP inoculation despite high assay2, March 12, 2014 ª2014 Elsevier Inc. 353
Figure 3. Viral MCK2 Chemokine Regulates PM Recruitment to MCMV-Inoculated FPs
(A–F) Initial cell recruitment patterns of CX3CR1+ PMs (A and B), NK cells (C and D), and IMs (E and F) shown as frequencies along with statistical comparison of
groups at the same time points.
(G) The second phase of MCK2-dependent PM recruitment shown as total PMs at 1, 3, and 5 dpi. CD45+ cells were isolated from Cx3cr1gfp/+ and Cx3cr1gfp/gfp
mice inoculated with either Mck2+ or mutant virus and evaluated by flow cytometry.
(H) FP swelling measured by digital caliper. Symbols show mean values ±SE for n = 5 mice. *p < 0.05; **p < 0.01; ***p < 0.001; n.s. indicates not significant
(p > 0.05). See also Figures S1 and S2.
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detected following systemic (ip) inoculation. This is likely due to
the ip route circumventing the robust NK response induced at a
local inoculation site. In controlMck2+ virus-infectedCx3cr1gfp/+
mice, PM numbers increased from 1 dpi to 5 dpi whether abso-
lute numbers (data not shown) or proportion of PBL (Figure 4A,
left panel) was assessed. In contrast, viremia in Cx3cr1 gfp/gfp
mice was lower and did not rise after 3 dpi. PM accumulation
was much lower during Mck2mut virus infection of both
Cx3cr1gfp/+ andCx3cr1gfp/gfp mice (Figure 4A, right panel). These
results prompted us to focus specifically on CX3CR1-dependent
PM function. When virus-positive PBL numbers were compared,
three times more virus-positive cells were detected at 3 dpi in
Cx3cr1gfp/+ compared to Cx3cr1gfp/gfp mice (Figure 4B). Thus,
virus dissemination was strongly tied to CX3CR1+ PM availabil-
ity. To identify the virus-positive subset, myeloid cells were
sorted and subjected to infectious centers assay. Consistent
with the CX3CR1-dependent pattern of viremia, MCMV was
detected exclusively in PMs (Figure 4C) and was absent in IMs
or neutrophils. Even though systemic administration overcomes
a CX3CR1-dependent step in seeding salivary glands (see Fig-
ure 1A), the virus still targets PMs. Thus, MCK2-responsive,354 Cell Host & Microbe 15, 351–362, March 12, 2014 ª2014 ElsevieCX3CR1-dependent PMs emerge as the sole myelomonocytic
lineage functioning as vehicles to support viral dissemination.
Onceplaced in culture, PMsand IMs isolated fromblooddiffer-
entiated intomacrophages thatwereequally susceptible to tissue
culture stockMCMV—a type of virus preparation that reflects the
quality of virus produced in host tissuesoutsideof salivary glands.
At high multiplicity of infection (m.o.i.), all macrophages were
100% IE1+ by 24 hpi (Figures 4D and 4E). At lower m.o.i., both
macrophage preparations were also equally susceptible to infec-
tion (datanot shown).Consistently,macrophagesgenerated from
both monocyte lineages supported similar levels of viral replica-
tion (Figure 4F). As expected (Mims and Gould, 1978), macro-
phages were less susceptible to infection with salivary gland
stock virus (Figures 4D and 4E). Thus, the process of natural
dissemination is mediated by CX3CR1-dependent PMs, which
are highly susceptible cells recruited to initial infection sites to
serve as dissemination vehicles capable of seeding tissue-resi-
dent macrophages that may arise from either monocyte subset.
PMs Disseminate Virus to Promote Systemic Infection
PBLs mediate transfusion-transmitted CMV infection in humans
(Prince et al., 1971; Yeager, 1974). Horizontal transmission hasr Inc.
Figure 4. PMs Harbor Infectious MCMV in Blood
(A) Time course of PM levels in PBL of Cx3cr1gfp/+ and Cx3cr1gfp/gfp mice infected with Mck2+ (left panel) or mutant (right panel) virus.
(B) Time course of PBL-associated viremia assessed by infectious centers assay.
(C) Identification of PBL harboring infectious virus. PM indicates patrolling monocytes, IM indicates inflammatory monocytes, and Neut indicates neutrophils.
Mice were inoculated via the ip route, and blood was collected at stated time points. PBLs or flow cytometry-sorted subsets were assessed by infectious centers
assays. Symbols are mean values ±SE for n = 5–10 mice.
(D–F) Infection of PM- or IM-derived macrophages with tissue culture (TC) (D–F) or salivary gland (SG) (D and E) stock virus.
(E) Frequencies of IE1+ cells.
(F) Virus replication. Data points are mean values ±SE.
(G) Transfer of infection by Cx3cr1gfp/+ CD45+ PBLs, PM-depleted CD45+ PBLs, or sorted PMs to naive Cx3cr1gfp/gfp recipient mice. *p < 0.05; **p < 0.01; ***p <
0.001; n.s. indicates not significant (p > 0.05).
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(Cheung and Lang, 1977; Roback et al., 2006). We employed a
transfusion model to investigate whether PM-mediated MCMVCell Hodissemination is sufficient to promote systemic infection.
Cx3cr1gfp/gfp naive recipients were transfused with either nonde-
pleted, PM-depleted or the sorted PM components of CD45+st & Microbe 15, 351–362, March 12, 2014 ª2014 Elsevier Inc. 355
Figure 5. Impact of CX3CR1 on Splenic PM
and Viral Levels during Acute Infection as
well as Reactivation from Latency
(A and B) (A) Total PMs at 1, 3, and 5 dpi and (B)
viral titers at 1, 3, 5, and 14 dpi in spleens of
Cx3cr1gfp/+ and Cx3cr1gfp/gfp mice during acute
infection. Micewere infected via the FP inoculation
route. Horizontal line represents assay threshold.
PMswere enumerated by flow cytometry, and viral
titers were obtained by plaque assay. Symbols are
mean values ±SE for groups of five to eight mice.
*p < 0.05; ***p < 0.001.
(C)Reactivationof latentMCMVinexplantedspleen
collected at 63dpi followingFP inoculation. Tissues
weresectioned into threeportions,andsupernatant
sampled at weekly intervals was titered by plaque
assay. Bars show the percentage of groups of five
animals whose splenic tissue yielded virus.
Cell Host & Microbe
Patrolling Monocytes Mediate MCMV DisseminationPBLs isolated from Cx3cr1gfp/+ mice at the peak in viremia.
Recipient salivary glands were harvested and titered at
14 days posttransfer (Figure 4G). Nondepleted CD45+ cells
(0.068% infectivity) transmitted infection to 100% of the recipi-
ents (Figure 4G). PM depletion decreased infectivity to 42% of
the nondepleted population. In contrast, sorted PMs were en-
riched with infected cells (5.25% infectivity) that transferred
infection with high efficiency, yielding 1,000-fold higher titers in
salivary glands versus nondepleted PBLs. Remarkably, engraft-
ing Cx3cr1gfp/gfp mice with infected donor Cx3cr1gfp/+ PMs
resulted in comparable virus levels in the salivary glands as in
directly infected Cx3cr1gfp/+ mice (Figure 1). The data here pro-
vide further evidence bolstering the PM contribution to MCMV
dissemination.
PM Lineage Cells Dictate Peak Splenic Titers and
Influence Latency
Macrophages and myeloid progenitors that give rise to these
cells have been implicated as sites of HCMV (Sinclair, 2008a)
as well as MCMV latency (Mitchell et al., 1996; Pollock et al.,
1997). Spleens were collected to investigate the contribution of
PMs to acute infection. Total numbers of CX3CR1hi PMs re-
cruited to spleens at 3 dpi were significantly compromised in
the absence of CX3CR1; although, levels were comparable at
5 dpi (Figure 5A). MCMV dissemination to and infection of the
spleen correlated with PMs such that higher peak titers of virus
were detected in Cx3cr1gfp/+ mice 2 days after PM numbers
were elevated (5 dpi)—a timewhen titers inCx3cr1gfp/gfp mice re-
mained low (Figure 5B). As replication levels early in infection
directly correlate with latency outcome, spleens were harvested
from mice at 63 dpi when no ongoing lytic infection in tissues,
including salivary glands, is detected (data not shown). Virus re-
activation was not detected in explants from Cx3cr1gfp/gfp mice,
whereas Cx3cr1gfp/+ tissues became positive by 28 days in cul-
ture (Figure 5C), and when evaluated in salivary glands, twice as
manyCx3cr1gfp/+ explants reactivated. Differences in spleen and
salivary gland outcomes may stem from the gross differences in
antiviral mechanisms that function in these sites (Reddehase
et al., 2008). All lung, liver, and BM explants remained negative
(data not shown). Together, the data here show a consistent
pattern of viral biology that depends on PMs for optimal systemic
infection in the natural host. Cells that traffic virus during acute356 Cell Host & Microbe 15, 351–362, March 12, 2014 ª2014 Elsevieinfection also act either as vehicles or direct host cells during
latency, an area of investigation that may now be pursued
more directly as a result of our observations. Thus, MCMV em-
ploys MCK2 to regulate recruitment of CX3CR1-dependent
PMs to infected tissues that are exploited by the virus for
dissemination, peak viral titers in spleen, and persistent infection
of salivary glands that ultimately influence patterns of latency
that may be detected in spleen and salivary glands.
NK and CD8 T Cell Antiviral Control Proceeds
Independent of CX3CR1
CX3CR1 is expressed on NK and CD8 T cells in addition to PMs.
Both lymphocyte types are central to control of MCMV in C57BL/
6 mice. Although CX3CR1 deficiency compromises PM mobili-
zation (Landsman et al., 2009), the impact on NK and CD8
T cells has not been fully elucidated. MCK2-recruited IMs
contribute to a potent NK cell response to MCMV (Crane et al.,
2009; Hokeness et al., 2005). We observed the expected
(Daley-Bauer et al., 2012) robust MCK2-dependent recruitment
of IMs by 3 dpi in FPs (Figure 6A, inset) as well as efficient NK
cell recruitment unaffected by CX3CR1 deficiency (Figures 6A
and 6B). Thus, NK cell recruitment was more dependent on viral
MCK2 and host IMs than on CX3CR1 or PMs, a pattern that
continued through 5 dpi. Importantly, this pattern of NK cell
recruitment resulted in more rapid control when MCK2 was
expressed (Figures 6C and 6D). In the absence of MCK2, viral
titers were higher and clearance was slower, consistent with
NK cell function being more responsive to MCK2 than to
CX3CR1 signaling. A similar impact on function was observed
in draining, popliteal lymph nodes (Figures 6E–6H). These data
reinforce the dominance of MCK2 recruitment of IMs in NK cell
responses (Crane et al., 2009; Hokeness et al., 2005) and sug-
gest that CX3CR1 does not contribute markedly to NK cell
response parameters during MCMV infection.
In addition to the host defense benefit of the IM-driven NK cell
response, NK-cell-mediated suppression of the effector CD8
T cell response has been observed in C57BL/6 mice (Andrews
et al., 2010; Su et al., 2001). The contribution of CX3CR1 to the
systemic antiviral CD8 T cell response was evaluated in the
spleen. Mck2+ virus-infected Cx3cr1gfp/+ and Cx3cr1gfp/gfp
mice mounted comparable responses in all parameters as-
sessed (Figures 6I–6L): proliferation, assessed as increase inr Inc.
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the Ag-experienced compartment detected as CD8loCD11a+
cells (Masopust et al., 2007) (Figure 6J); differentiation, based
on increased KLRG1 and decreased CD62L and CD127 expres-
sion (Figure 6K; data not shown); and MCMV M45 peptide-
induced cytokine production (Figure 6L). The MCK2- and
IM-dependent pattern of CD8 T cell suppression was observed
only in Cx3cr1gfp/+ but was absent in Cx3cr1gfp/gfp mice (Fig-
ure 6L). Given the apparent immune competence of CX3CR1-
deficient mice, the defect in MCMV dissemination and latency
appears to result from an intrinsic compromise of PM function
rather than from any system-wide immune deficiency.
DISCUSSION
Here, CX3CR1-dependent PMs are identified as the myelomo-
nocytic cell type responsible for CMV dissemination in the natu-
ral host. We show that MCMV-encoded MCK2 recruits PMs as
well as IMs, exploiting both major monocyte populations. IMs
modulate antiviral immunity, primarily by impairing CD8 T cells
(Daley-Bauer et al., 2012). PMs acquire virus from initial infection
sites and mask the virus from the immune response, ensuring
delivery to distal organs via the blood. In this capacity, PMs func-
tion as dissemination vehicles dictating maximal viral loads in
spleen and persistence in salivary glands. This pattern dictates
latency outcome in these tissues. Monocytes are well-recog-
nized primary targets during HCMV infection (Daley-Bauer and
Mocarski, 2012; Sinclair, 2008a), although focus has been on
CD14+ subsets that behave like mouse CCR2+ IMs. The biolog-
ical parallels between CX3CR1hi mouse and CD16+ human PMs
suggest studies focused on this less abundant population in
HCMV pathogenesis and latency might be fruitful.
HCMV dissemination may also be influenced by viral chemo-
kines (Daley-Bauer and Mocarski, 2012; Penfold et al., 1999),
although species specificity has not allowed elaboration of this
contribution. The MCMV study here demonstrates that a viral
chemokine can recruit and hijack both monocyte subsets to
create a pathogen-host balance that promotes infection.
MCK2 amplifies the biphasic chemotaxis of CX3CR1hi PMs to
disseminate virus and the CCR2+ IMs to dampen antiviral CD8
T cell immunity (Daley-Bauer et al., 2012). The first phase of
PM recruitment contributes to the initial NK cell response
(French et al., 2006), analogous to IM-mediated modulation of
NK cells later in infection (Crane et al., 2009; Hokeness et al.,
2005). The second PM recruitment phase is precipitated by a
MCK2-CX3CR1 synergy that ensures optimal numbers of sus-
ceptible cells are present to acquire virus when viral levels
peak. Studies suggested a CCR2-dependent IM effect on NK
cell response (Crane et al., 2009; Hokeness et al., 2005) that im-
pairs the adaptive immunity in MCMV-infected C57BL/6 mice
(Andrews et al., 2010; Su et al., 2001). Here, we expand under-
standing of the immunomodulatory MCK2-IM axis to show that
this drives the potent antiviral NK cell response limiting CD8
T cell priming. In BALB/c mice where the NK cell response is
negligible, immunosuppression is achieved by a direct impact
of IMs on the CD8 T cell response (Daley-Bauer et al., 2012).
The importance of MCK2 in governing monocyte-driven activ-
ities ensuring successful infection has significant implications
for studies that employ MCK2-deficient Smith strain bacmid-Cell Hoderived viruses (Jordan et al., 2011). Recent evidence impli-
cating MCK2 as a mediator of viral entry into macrophages
(Wagner et al., 2013) was not sustained by independently con-
structed, well-characterized K181 strain-derived mutant and
repaired rescue viruses used in our studies. This draws into
question any general role in entry but reinforces the contribution
of MCK2 chemokine activity in viral dissemination (Noda et al.,
2006; Saederup et al., 1999, 2001). Thus, MCMV relies on viral
chemokine-dependent strategies as an integral component of
pathogenesis.
Our observations point to key contributions of PM-lineage cells
in CMV pathogenesis, extending the understanding of events
that lead to systemic infection (Daley-Bauer and Mocarski,
2012; Hsu et al., 2009; Manning et al., 1992; Noda et al., 2006;
Sacher et al., 2008; Saederup et al., 2001; Stoddart et al.,
1994). By comparing local and systemic inoculation, we show
that a MCK2-responsive, CX3CR1-dependent, PM-associated
viremia occurs independent of route, whereas the requirement
for CX3CR1 to support dissemination to salivary glands is very
much inoculation route dependent. As PMs retain the immature
monocyte phenotype and circulate in blood, we speculate that
they encounter and acquire virus through contact with infected
vascular endothelial cells at local sites of infection—a step that
is bypassed by systemic inoculation (Hsu et al., 2009; Sacher
et al., 2008). Most importantly, our data support the crucial
contribution of PMs for peak splenic titers as well as persistent
levels of virus in salivary glands that correlate with the establish-
ment of lifelong latency. We therefore propose a model for the
natural process of MCMV infection: (i) replication in parenchymal
and endothelial cells at primary infection sites (Hsu et al., 2009;
Sacher et al., 2008); (ii) MCK2-enhanced PM recruitment to these
sites; (iii) infection of PMs; (iii) trafficking of PMs via the blood
stream to distal organs; (iv) differentiation into permissivemacro-
phages and dendritic cells capable of seeding virus-susceptible
tissues; and (v) establishment of a PM lineage-driven latent reser-
voir following immune control of acute infection. This patternmay
parallel a process in HCMV pathogenesis where more informa-
tion is needed on whether vCXCL1 chemokine (Penfold et al.,
1999) recruits monocytes to enhance dissemination and/or
latency (Sinclair, 2008a). Therapeutic disruption of this process
would be predicted to cut short dissemination and preclude
latency, as occurs in CX3CR1-deficient mice.
The ontogeny of murine monocytes is becoming more
clearly understood. Under steady-state conditions, BM-resident,
short-lived CX3CR1intLy6Chi IMs precursors give rise to
CX3CR1hiLy6C PMs (Varol et al., 2007; Yona et al., 2013). PMs
may also arise from an IM-independent precursor (Hanna et al.,
2011). Given thewell-established relationship between differenti-
ation state and susceptibility to CMVs, IMsmay represent imma-
ture (F4/80lo) and PMsmay represent sufficiently mature (F4/80+)
cells, even though both are able to differentiate into virus-suscep-
tible macrophages. Further, IMs extravasate into tissues in
response to inflammatory insult (Carlin et al., 2013).Differentiation
of IMs into macrophages that support infection may occur in tis-
sues and not in the bloodstream. Given that MCK2 amplifies IM
recruitment to infected tissues (Daley-Bauer et al., 2012), macro-
phages that support viral replication may certainly be IM derived.
The contribution of PMs to establishing a latent reservoir of
MCMVhas implications for investigations ofHCMVpathogenesisst & Microbe 15, 351–362, March 12, 2014 ª2014 Elsevier Inc. 357
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cells that give rise to monocytes, macrophages, and dendritic
cells (Keyes et al., 2012; Reeves et al., 2005; Riegler et al.,
2000; Rossetto et al., 2013; So¨derberg-Naucle´r et al., 2001; Tay-
lor-Wiedeman et al., 1991). Blood monocytes, in particular, have
contributed to understanding of host-pathogen mechanisms
involved in both lytic and latent infections. CD14loCD16+ PMs
are a minor population (7%) of human blood monocytes where
IMs represent the majority (90%) and include two distinct phe-
notypes, CD14+CD16 and CD14+CD16+ (Cros et al., 2010).
Although recent focus has been on CD14+-enriched monocytes
(Avdic et al., 2013; Huang et al., 2012; Poole et al., 2013), PMs
may also contribute to the biology of HCMV. Studies that have
attributed CD14+ monocyte-derived lineage cells as sites of la-
tency capable of supporting viral reactivation upon differentiation
in vitro (Keyes et al., 2012; Riegler et al., 2000; Rossetto et al.,
2013; So¨derberg-Naucle´r et al., 2001; Taylor-Wiedeman et al.,
1991) seem more reminiscent of the behavior of IMs in mice
that play no physiologic role in dissemination or latency (Daley-
Bauer et al., 2012) but can be infected in vitro. Given the low
numbers of latent viral-DNA-positive cells in blood of healthy in-
dividuals (Slobedman and Mocarski, 1999), additional investiga-
tion of CD16+ PMs may clarify mechanisms and relevant cell
types in HCMV pathogenesis.
The specific cell types that are important in harboring latent
virus have been a longstanding topic of interest. Monocytes
and myelomonocytic progenitors are apparent sites of CMV
latency in both mice (Reddehase et al., 2008) and humans (Sin-
clair, 2008a), and the role these cells play in dissemination or
persistence would potentially disrupt the path to latency. The
discrepancy between our data and a recently published study
excluding CX3CR1hi PM lineage cells as sites of latency in lungs
(Marquardt et al., 2011) may reflect the following: (i) the use
of an attenuated MCK2 mutant with reduced ability to infect
monocytes (Jordan et al., 2011; Wagner et al., 2013; Wagner
et al., 1999), (ii) reliance on a systemic inoculation route that
bypasses PM-associated steps in dissemination and latency,
and/or (iii) a specialized feature of lung infection that remains
to be elaborated.
Collectively, we have shown that PM lineage cells contribute
to viral dissemination, peak replication, persistent infection,
and detection of latency, defining a major monocyte population
targeted by a viral chemokine that contributes to the success of
viral pathogenesis. Our approach reinforces the importance of
infection route used in animal models in elucidating mechanisms
involved in pathogenesis. The study reveals that CMV evolved a
chemokine-driven modulatory strategy that exploits one arm of
the monocyte compartment primarily to perpetuate infection
and the other arm to modulate host immune control to achieveFigure 6. CX3CR1 Deficiency Does Not Impair Antiviral Immune Respo
(A–D) NK cell levels (A and B) and viral titers (C and D) in inoculated FPs. Inset s
(E–H) NK cell levels (E and F) and viral titers (G and H) in draining popliteal lymph
(I–L) Systemic CD8 T cell response in spleens at 7 dpi. Shown are (I) total CD8 T ce
experienced cells were further characterized to identify effector T cells based (K
peptide stimulation. Bars show mean values ±SE for n = 5 Cx3cr1gfp/+ (black) or C
(open) virus infection via the FP route. Cells were isolated from respective tissue
plaque assay for viral load. Data points are mean values ±SE for n = 5 mice, and h
indicates not significant (p > 0.05).
Cell Hoa pathogen-host balance. We predict the full appreciation of
the contributions of monocyte lineages to HCMV pathogenesis
will benefit from studies investigating CD16+ PMs in parallel
with the more abundant CD14+ IMs. These findings will have
bold implications for improving vaccine and therapeutic strate-
gies targeting HCMV, as well as for preventing transmission to
susceptible recipients by transfusion and transplantation.
EXPERIMENTAL PROCEDURES
Viruses, Mice, and Experimental Infection
MCMV K181+-derived recombinant Mck2 mutant (RM461) and rescued
(RQ461) viruses (Stoddart et al., 1994) were propagated in NIH 3T3 murine fi-
broblasts (ATCC CRL-1658) (Manning et al., 1992). Virus was prepared from
clarified infected cell medium (Saederup et al., 1999) and used to inoculate
8- to 16-week-old mice. Cx3cr1gfp/gfp C57BL6 mice (Jung et al., 2000) (JAX
#05582) were crossed with wild-type C57BL/6 (JAX #00664) mice to produce
Cx3cr1gfp/+ offspring used as controls. Mice were inoculated either ip (13 106
plaque-forming units [PFU]) or in a hind FP (5 3 106 PFU) with virus diluted in
medium. Mock infection was with virus-free medium. Mice were housed at the
Emory University Division of Animal Resources, and experiments were con-
ducted in accordance with National Institutes of Health and Emory University
Institutional Animal Care and Use Committee guidelines.
Plaque and Infectious Center Assays
Plaque assays were conducted on tissues homogenized in medium (Manning
et al., 1992) or sonicated macrophages and supernatant harvested from cul-
tures and infectious assays on blood leukocyte suspensions overlaid onto
3T3 Swiss Albino (3T3-SA) murine fibroblasts (ATCC CCL-92). Virus titers
were calculated at 4 days when cells were fixed with methanol and stained
with Giemsa for plaque visualization.
Antibodies
Antibodies toCD16/32 (FcgRII/III; Clone2.4G2), Ly6C (CloneAL21), Ly6G (Clone
1A8), TNF-a (Clone MP6-XT22), CD4 (Clone RM4-5), CD11b (Clone M1/70),
CD3ε (Clone 500A2), and NK1.1 (Clone PK136) were purchased from BD
PharMingen; CD45 (Clone 30F11), CD69 (H1.2F3), and F4/80 (Clone BM8)
from Invitrogen; IFN-g (Clone XMG1.2), CD62L (Clone MEL14), CD115 (Clone
ASF98), and CD107a (Clone 1D4B) from Biolegend; and CD4 (Clone GK1.5),
CD11c (Clone N418), Ly-6A/E (Sca-1; Clone D7), CD19 (Clone 1D3), CD31
(PECAM-1; Clone 390), CD8a (Clone 53-6.7), CD49b (Clone DX5), Siglec H
(Clone eBio440c), CD3ε (Clone 17A2), and Ly6C/6G (Gr-1; Clone RB6.8C5)
from eBioscience.
Tissue Collection, Leukocyte Preparation, and Flow Cytometry
Single-cell suspensions were prepared from tissues as follows: FPs were
minced into 3 mm sections and digested with collagenase D (1.5 mg/ml;
Sigma) in PBS, spleens and pLNs were mashed through a metal sieve, and
blood cells separated on Histopaque-1119 (Sigma) density medium. Following
hypotonic lysis of erythrocytes, suspensions were filtered (40 mm mesh), and
viable cell counts were performed with trypan blue dye exclusion on a hema-
cytometer. Cell surface FcgRII/III was blocked prior to incubating with Abs for
multiparametric flow cytometric analyses. Data were acquired by flow cytom-
etry (BD LSRII cytometer and FACSDiva Software; BD Biosciences), analyzed
with FlowJo (TreeStar), and graphed with Prism (GraphPad).nse
hows IM numbers at 3 dpi.
nodes.
lls and (J) the Ag-experienced population identified as CD8aloCD11a+ cells. Ag-
) KLRG1 expression and (L) intracellular IFNg and TNF following MCMV M45
x3cr1gfp/gfp (gray) mice subjected to mock (striped),Mck2+ (filled), orMck2mut
s and quantified by flow cytometry. Homogenized tissues were assessed by
orizontal lines represent assay threshold. *p < 0.05; **p < 0.01; ***p < 0.001; n.s.
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Patrolling Monocytes Mediate MCMV DisseminationCells were sorted (purity >90%; FACSVantage, BD Biosciences) from blood
of Cx3cr1gfp/+ mice for adoptive transfer experiments or in vitro differentiation
of macrophages.
Adoptive Transfer of Infectivity
Mice were inoculated ip with 3.53 106 PFU virus, and blood was collected at 3
dpi. Blood leukocytes were prepared, stained, and sorted by flow cytometry.
Purified leukocytes were injected into tail veins of naive recipient mice, and
salivary glands were collected at 14 dpi. Viral titers were calculated by plaque
assay.
MCMV Infection of Monocyte-Derived Macrophages
Blood cells were prepared for flow cytometry, andmonocyte subsets were iso-
lated as described above. Purified PMs and IMs were suspended in complete
Dulbecco’s modified Eagle’s medium containing 20% fetal calf serum supple-
mented with 10% L929-conditioned medium. After 7 days of culture with fresh
medium every 3 days, adherent, differentiated macrophages were inoculated
with tissue-culture-derived (RQ461) stock or salivary-gland-derived (v70)
stock at an m.o.i. of 10 for 24 or 96 hr. Viral replication by plaque assay on
supernatant was collected daily for 4 days.
Macrophages were washed with PBS and then fixed with 4% formal-
dehyde (EMS). Autofluorescence was quenched with 50 mM NH4Cl,
cells were permeabilized with 0.5% Triton X-100, and nonspecific binding
was blocked with PBS containing 0.1% BSA and 5% normal donkey
serum. Anti-IE1 (Croma101) was added and bound antibodies were
detected with donkey anti-mouse IgG (Alexa Fluor 594; BD Bioscience).
Images were obtained using a Zeiss Axio Imager A1 epifluorescence
microscope.
Latent Infections and Explant Reactivation
Groups of five Cx3cr1gfp/gfp or Cx3cr1gfp/+ C57BL6 mice were inoculated
as described above; the salivary glands, lung, liver, spleen, and BM were
collected at 63 dpi, divided into three portions, minced into 3 mm pieces,
and placed into culture with supernatant collected from culture wells and
replaced with fresh culture medium at weekly intervals for 5 weeks. Reactiva-
tion of virus was assessed by plaque assay of culture supernatants on 3T3-SA
fibroblasts.
Statistical Analysis
Experimental groups contained a minimum of five mice. Statistical differences
between groups were calculated by Student’s t test, one-way ANOVA with
Bonferroni’s or Dunnett’s Multiple Comparison posttest, or two-way ANOVA
with Bonferroni’s Multiple Comparison posttest where p% 0.05 was consid-
ered significant using the GraphPad Prism 5 software.
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